Hepatocellular Carcinoma and Transarterial Chemo-Embolization
The most well-known kind of adult essential liver growth and the most common cause of death in cirrhotic people is hepatocellular carcinoma (HCC). It occurs when the liver is constantly becoming worse and is most strongly linked to chronic viral hepatitis infection (hepatitis B or C) or exposure to toxins like alcohol or aflatoxin. Alpha 1-antitrypsin deficiency and hemochromatosis are two conditions that increase the risk of treating HCC. Similar to other malignancies, HCC therapy and prognosis depend on the characteristics of the, tumor's histology measurement, extent of growth, and overall health.
Related Conference of Hepatocellular Carcinoma and Transarterial Chemo-Embolization
April 14-15, 2025
25th International Conference on Gastroenterology and Hepatology
Budapest, Hungary
June 04-05, 2025
25th International Conference on Gastroenterology and Hepatology
Edinburgh, Scotland
Hepatocellular Carcinoma and Transarterial Chemo-Embolization Conference Speakers
Recommended Sessions
- Clinical Trials on Hepatology
- Hepatitis and its Types
- Hepatitis Vaccination
- Hepatitis, Liver Diseases and Pregnancy
- Hepatitis: Screening and Testing Methods
- Hepato-Nephrology and Pathology
- Hepato-Radiology
- Hepatocellular Carcinoma and Transarterial Chemo-Embolization
- Hepatology and Nutrition
- Inherited Liver Diseases
- Liver and Biliary
- Liver Biopsy
- Liver Cirrhosis
- Liver Diseases
- Liver Function
- Liver Injury and Immune Responses
- Liver Transplantation and surgery
- Prevention and Treatment for Hepatitis
- Stem cell treatment on Liver Diseases
Related Journals
Are you interested in
- Adolescent Gynecology and Pediatric Gynecology - Euro Gynecology Congress 2025 (Czech Republic)
- Advanced Laparoscopic and Robotic Surgery in Gynecology - Euro Gynecology Congress 2025 (Czech Republic)
- Advanced Liver Regeneration and Stem Cell Research - Gastroenterology 2025 (Scotland)
- Advanced Techniques in Gastrointestinal Imaging - Gastroenterology 2025 (Scotland)
- Advanced Therapy and Treatments Techniques - Liver Diseases 2025 (UK)
- Advancements in Non-invasive Liver Diagnostic - Gastroenterology 2025 (Scotland)
- Advances in Endoscopic Techniques and Innovations - Gastroenterology 2025 (Scotland)
- Advances in Gastrointestinal Endoscopy - Gastroenterology Conference 2025 (France)
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2025 (UAE)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2025 (UAE)
- Advances in Gut-Associated Lymphoid Tissue (GALT) and Immunity - Gastroenterology 2025 (Scotland)
- Advances in Hepatocellular Carcinoma Treatment - Gastroenterology Conference 2025 (France)
- Advances in Pancreatitis Treatment: Managing Acute and Chronic Cases - Gastroenterology 2025 (Scotland)
- AI in Early Diagnosis of Colorectal Cancer - Gastroenterology 2025 (Scotland)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2025 (UAE)
- Antiviral Resistance - HEPATITIS 2025 (France)
- Artificial Intelligence and Digital Health in Gastroenterology - Gastroenterology-2024 (UAE)
- Artificial Intelligence and Digital Health in Gastroenterology and Hepatology - Liver Diseases 2025 (UK)
- Assisted Reproductive Technology (ART) - Euro Gynecology Congress 2025 (Czech Republic)
- Autoimmune Liver Diseases - Gastroenterology Conference 2025 (France)
- Bariatric and Metabolic Surgery - Gastroenterology-2024 (UAE)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2025 (UAE)
- Biliary Tract Disorders - Gastroenterology Conference 2025 (France)
- Biomarkers for Gastrointestinal Diseases - Gastroenterology-2024 (UAE)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2025 (UAE)
- Challenges in Gastroenterology Drug Development - Gastroenterology Conference 2025 (France)
- Clinical Research in Gastroenterology and Liver Diseases - Liver Diseases 2025 (UK)
- Colorectal Cancer Screening and Prevention - Gastroenterology Conference 2025 (France)
- Colorectal Cancer Screening and Surveillance - Gastroenterology-2024 (UAE)
- Colorectal Cancer: Early Detection, Diagnosis, and Therapeutics - Gastroenterology 2025 (Scotland)
- CRISPR-Cas9 in Gastrointestinal and Hepatic Disease Research - Gastroenterology 2025 (Scotland)
- Diagnostic Technologies - HEPATITIS 2025 (France)
- Drug-Induced Liver Injury - Gastroenterology Conference 2025 (France)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2025 (UAE)
- Emerging Trends in Gastrointestinal Oncology - Gastroenterology Conference 2025 (France)
- Endoscopic Innovations in Gastrointestinal Disorders - Gastroenterology-2024 (UAE)
- Endoscopic Ultrasound in Gastroenterology - Gastroenterology Conference 2025 (France)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2025 (UAE)
- Esophageal Disorders: Diagnosis and Management - Gastroenterology Conference 2025 (France)
- Fecal Microbiota Transplantation (FMT) and Its Therapeutic Applications - Gastroenterology 2025 (Scotland)
- Functional Gastrointestinal Disorders (FGIDs) - Gastroenterology-2024 (UAE)
- Gastro Screening and Diagnosis - Liver Diseases 2025 (UK)
- Gastroenterological Complications of Diabetes - Gastroenterology Conference 2025 (France)
- Gastroenterology - Liver Diseases 2025 (UK)
- Gastroenterology & Pregnancy - Liver Diseases 2025 (UK)
- Gastroenterology and Liver - Gastroenterology Conference 2025 (France)
- Gastrointestinal Bleeding: Diagnosis and Management - Gastroenterology Conference 2025 (France)
- Gastrointestinal Diseases and Disorders - Liver Diseases 2025 (UK)
- Gastrointestinal Disorders in Pregnancy - Gastroenterology Conference 2025 (France)
- Gastrointestinal Endoscopy - Liver Diseases 2025 (UK)
- Gastrointestinal Inflammation and Treatment - Liver Diseases 2025 (UK)
- Gastrointestinal Motility Disorders - Gastroenterology-2024 (UAE)
- Gastrointestinal Motility Disorders - Gastroenterology Conference 2025 (France)
- Gastrointestinal Oncology - Gastroenterology-2024 (UAE)
- Gastrointestinal Oncology - Liver Diseases 2025 (UK)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2025 (UAE)
- Gastrointestinal Surgery - Liver Diseases 2025 (UK)
- Gastrointestinal Symptoms in Systemic Diseases - Gastroenterology Conference 2025 (France)
- Genetic and Epigenetic Innovations in Gastroenterology - Gastroenterology 2025 (Scotland)
- Genetic and Immunological Mechanisms in Autoimmune Gastrointestinal Disorders - Gastroenterology 2025 (Scotland)
- Genetic Markers for Predicting Inflammatory Responses in Liver Disease - Gastroenterology 2025 (Scotland)
- Genetic Pathways in Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH - Gastroenterology 2025 (Scotland)
- Global Health Initiatives - HEPATITIS 2025 (France)
- Global Hepatitis Burden - HEPATITIS 2025 (France)
- Gut Microbiome - Digestive Health - Liver Diseases 2025 (UK)
- Gut Microbiota and Digestive Health - Gastroenterology-2024 (UAE)
- Gut-Brain Connection in Gastroenterology - Gastroenterology 2025 (Scotland)
- Gynaecologic oncology - Euro Gynecology Congress 2025 (Czech Republic)
- Gynecologic Diseases - Euro Gynecology Congress 2025 (Czech Republic)
- Gynecologic surgery - Euro Gynecology Congress 2025 (Czech Republic)
- HBV Management - HEPATITIS 2025 (France)
- HCV Treatment - HEPATITIS 2025 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2025 (UAE)
- Hepatic Encephalopathy: Pathogenesis and Treatment - Gastroenterology Conference 2025 (France)
- Hepatitis - Liver Diseases 2025 (UK)
- Hepatitis & Liver Cancer - HEPATITIS 2025 (France)
- Hepatitis B and C: Current and Future Therapies - Gastroenterology Conference 2025 (France)
- Hepatitis B and Hepatitis C - Gastroenterology-2024 (UAE)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2025 (UAE)
- Hepatitis Co-Infections - HEPATITIS 2025 (France)
- Hepatitis D: The Silent Epidemic in Hepatology - Gastroenterology 2025 (Scotland)
- Hepatitis E: Latest Updates and Research - Gastroenterology 2025 (Scotland)
- Hepatitis Types - HEPATITIS 2025 (France)
- Hepatitis Vaccines - HEPATITIS 2025 (France)
- Hepatocellular Carcinoma (HCC) - Gastroenterology-2024 (UAE)
- Hepatocellular Carcinoma (HCC): Early Detection and Management - Gastroenterology 2025 (Scotland)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2025 (UAE)
- Immune Response - HEPATITIS 2025 (France)
- Immunology and Genetic Mechanisms in Liver Transplantation - Gastroenterology 2025 (Scotland)
- Immunotherapy in GI Cancer Treatment - Gastroenterology 2025 (Scotland)
- Innovations in Gastrointestinal Imaging - Gastroenterology Conference 2025 (France)
- Innovations in Gastrointestinal Surgery - Gastroenterology Conference 2025 (France)
- Innovations in Gynecology - Euro Gynecology Congress 2025 (Czech Republic)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2025 (UAE)
- Liver Cancer - Liver Diseases 2025 (UK)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2025 (UAE)
- Liver diseases - Liver Diseases 2025 (UK)
- Liver Fibrosis & Cirrhosis - HEPATITIS 2025 (France)
- Liver Fibrosis and Cirrhosis - Gastroenterology-2024 (UAE)
- Liver Fibrosis and Cirrhosis - Liver Diseases 2025 (UK)
- Liver Fibrosis: Assessment and Management - Gastroenterology Conference 2025 (France)
- Liver Regeneration and Stem Cell Therapy - Liver Diseases 2025 (UK)
- Liver Transplantation and Liver Biopsy - Liver Diseases 2025 (UK)
- Liver Transplantation and Regenerative Medicine - Gastroenterology-2024 (UAE)
- Liver Transplantation: Current Practices and Future Directions - Gastroenterology Conference 2025 (France)
- Management of Inflammatory Bowel Disease (IBD) - Gastroenterology Conference 2025 (France)
- Maternal-Fetal Medicine (MFM) - Euro Gynecology Congress 2025 (Czech Republic)
- Menopause and Hormone Replacement Therapy - Euro Gynecology Congress 2025 (Czech Republic)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2025 (UAE)
- Microbiome and Gut Health - Gastroenterology Conference 2025 (France)
- Microbiome and Gut Health - Gastroenterology 2025 (Scotland)
- Microbiome and Its Impact on Colorectal Cancer (CRC) - Gastroenterology 2025 (Scotland)
- Microbiome and Liver Health - Gastroenterology-2024 (UAE)
- Molecular Mechanisms in Liver Disease - Gastroenterology Conference 2025 (France)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2025 (UAE)
- Neuro Gastroenterology - Liver Diseases 2025 (UK)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2025 (UAE)
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) - Gastroenterology-2024 (UAE)
- Nutrition and Digestive Health - Gastroenterology-2024 (UAE)
- Nutrition in Hepatitis - HEPATITIS 2025 (France)
- Nutritional Management in Liver Disease - Gastroenterology Conference 2025 (France)
- Obstetric anesthesia and pain management - Euro Gynecology Congress 2025 (Czech Republic)
- Pancreatic Disorders & Diseases- Treatment - Liver Diseases 2025 (UK)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2025 (UAE)
- Patient-Centered Care - HEPATITIS 2025 (France)
- Patient-Centered Care in Gastroenterology - Gastroenterology Conference 2025 (France)
- Pediatric Gastroenterology - Gastroenterology-2024 (UAE)
- Pediatric Gastroenterology and Hepatology - Gastroenterology 2025 (Scotland)
- Pediatric Gastroenterology: Challenges and Innovations - Gastroenterology Conference 2025 (France)
- Personalized Medicine in Gastroenterology - Gastroenterology Conference 2025 (France)
- Prebiotics and Probiotics - Liver Diseases 2025 (UK)
- Precision Medicine in Gastrointestinal Cancers - Gastroenterology-2024 (UAE)
- Prevention Programs - HEPATITIS 2025 (France)
- Psychosocial Factors - HEPATITIS 2025 (France)
- Public Health Policies - HEPATITIS 2025 (France)
- Quality Improvement and Patient-Centered Care - Gastroenterology-2024 (UAE)
- Reproductive Endocrinology - Euro Gynecology Congress 2025 (Czech Republic)
- Research Innovations - HEPATITIS 2025 (France)
- Role of Artificial Intelligence in Clinical Decision Making - Gastroenterology 2025 (Scotland)
- Role of Artificial Intelligence in Gastroenterology - Gastroenterology Conference 2025 (France)
- Role of MicroRNAs in Genetic Regulation of Liver Diseases - Gastroenterology 2025 (Scotland)
- Special Populations - HEPATITIS 2025 (France)
- Stem Cell Therapy and Regenerative Medicine in Gastroenterology - Gastroenterology 2025 (Scotland)
- Substance Abuse - HEPATITIS 2025 (France)
- Targeting Genetic Pathways in Gastrointestinal Inflammation - Gastroenterology 2025 (Scotland)
- Therapeutic Advances in Inflammatory Bowel Disease (IBD) - Gastroenterology-2024 (UAE)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2025 (UAE)
- Translational Research in Gastroenterology and Hepatology - Gastroenterology 2025 (Scotland)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2025 (UAE)
- Upper GI Tract, small & Large Intestine - Liver Diseases 2025 (UK)
- Urogynecology and Pelvic Floor Disorders - Euro Gynecology Congress 2025 (Czech Republic)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2025 (UAE)